Chembio Diagnostics Inc. | Ownership
Companies that own Chembio Diagnostics Inc.
Acuta Capital Partners LLC
2,030,533
14.33%
23,866
3.7%
06/30/2018
Wellington Management Co. LLP
918,535
6.48%
0
0%
06/30/2018
ARS Investment Partners LLC
796,367
5.62%
-63,635
1.26%
06/30/2018
Cortina Asset Management LLC
645,718
4.55%
121,330
0.28%
06/30/2018
The Vanguard Group, Inc.
519,325
3.66%
0
0%
06/30/2018
Royce & Associates LP
299,353
2.11%
84,000
0.02%
06/30/2018
Gagnon Securities LLC
263,894
1.86%
62,196
0.72%
06/30/2018
Gagnon Advisors LLC
194,579
1.37%
65,006
1.19%
06/30/2018
Wells Fargo Clearing Services LLC
134,750
0.95%
-6,000
0%
06/30/2018
Benchmark Capital Advisors, Inc.
96,235
0.68%
21,143
0.75%
06/30/2018
| Address |
3661 Horseblock Road
Medford New York 11763
United States
|
|
Employees
|
- |
| Website |
http://www.chembio.com |
| Updated |
07/08/2019 |
| Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It sells its products under its STAT PAK, SURE CHECK, DPP and SampleTainer trademarks. The company was founded on May 5, 2004 and is headquartered in Medford, NY. |
